Biotech Snap

A daily 5-min biotech briefing

Latest news

Amgen taps into Disco Pharma's pipeline & GSK/Ionis have a 'functional cure' for hepatitis B

Joachim Eeckhout, +1

Amgen buys Dark Blue's protein degraders & Alumis' psoriasis pill shows big promise

Joachim Eeckhout, +1

Zenas drug trial success fails to impress Wall Street, shares crash 55%

Joachim Eeckhout, +1

The first new motion sickness drug since 1979 & Genmab's pipeline update

Joachim Eeckhout, +1

Takeda’s $4B psoriasis pill shows blockbuster promise & DBV's patch puts peanuts back on the menu

Joachim Eeckhout, +1

Ambros launches with $125M for non-opioid drugs & the EU proposes Biotech Act I

Joachim Eeckhout, +1

Yarrow buys a Chinese thyroid drug for $1.37B & Aviceda’s lead eye drug misses key trial

Joachim Eeckhout, +1

Kyverna's CAR-T win in autoimmune disease & Sanofi’s multiple sclerosis drug fails Phase 3

Joachim Eeckhout, +1

AC Immune's promising Parkinson ́s vaccine & a British biotech buys a US company for pennies per share

Joachim Eeckhout, +1

Lilly breaks records with 29% weight loss & Zealand inks $2.5B deal with China's OTR

Joachim Eeckhout

D3 Bio lands $108M for its KRAS cancer drug & Formation Bio launches a startup with a $605M deal

Joachim Eeckhout

Terns’ new data challenges Novartis & Pfizer buys a Chinese obesity pill

Joachim Eeckhout

1 2 3 4 5 6 7 8